Elisabeth A. te Velde

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol

Anke Kuijpers, B. Mirck, Arend G. J. Aalbers et al. · Annals of Surgical Oncology · 2013 · 233 citations · Full text

Medicine, Oncology, Surgery +17

Ischemia/Reperfusion Accelerates the Outgrowth of Hepatic Micrometastases in a Highly Standardized Murine Model *

Jarmila D.W. van der Bilt, Onno Kranenburg, Maarten W. Nijkamp et al. · Hepatology · 2005 · 181 citations · Full text

Medicine, Oncology, Carcinogenesis +13

Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial

Charlotte E.L. Klaver, Gijsbert D. Musters, Willem A. Bemelman et al. · BMC Cancer · 2015 · 133 citations · Full text

Medicine, Oncology, Surgery +17

Improving access to supportive cancer care through an e<scp>H</scp>ealth application: a qualitative needs assessment among cancer survivors

Sanne Lubberding, Cornelia F. van Uden‐Kraan, Elisabeth A. te Velde et al. · Journal of Clinical Nursing · 2015 · 125 citations · Full text

Nursing, Oncology, Cancer Survivorship Care +16

Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node

Kim M. van Pul, Ronald J.C.L.M. Vuylsteke, Rieneke van de Ven et al. · Journal for ImmunoTherapy of Cancer · 2019 · 67 citations · Full text

Medicine, Immunology, Oncology +17